Information for:

Resources

Theodore Johnson

Professor

Theodore Johnson

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Pediatrics: Hematology/Oncology

Medical College of Georgia
Department of Georgia Cancer Center

Medical College of Georgia
Department of Neuroscience and Regenerative Medicine

Administration
Department of The Graduate School

  • THJOHNSON@augusta.edu
  • (706) 721-4962
  • (706) 721-3925
  • CN 4142

Education

  • MD, Medicine Medical College of Georgia, 2004

  • Ph.D., Molecular Medicine. Augusta University, 2004

  • BS, Chemistry, General Georgia Institute of Technolog, 1997

Certifications

  • PHY Ga Comp Med Brd, 2010

Awards & Honors

  • Recognition of “a critical advance in the field of neuroscience” and invitation to give an encore presentation American Academy of Neurology (AAN) Science Committee, AAN 2023 Annual Meeting, Platform presentation, 2023

  • Exemplary Teaching Award MCG, 2021

  • Exemplary Teaching Award MCG, 2017

  • Outstanding Young Clinical Science Faculty Award Medical College of Georgia, Faculty Senate , 2014

  • Champion Award University System of Georgia, MD/PhD Program, 2012

Courses Taught Most Recent Academic Year

  • PEDS 5000

    Basic Clkshp in PEDS

  • PEDS 5009

    Pediatric Sub-I

  • RPED 5002

    Pediatrics General

Teaching Interests

I teach medical students and resident physicians in the art and science of pediatric hematology and oncology.

Scholarship

Selected Recent Publications

  • Indoximod-based chemo-immunotherapy for pediatric brain tumors: a first-in-children phase 1 trial, 2024
    Journal Article, Academic Journal
  • Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity, 2021
    Journal Article, Professional Journal
  • Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis, 2014
    Journal Article, Academic Journal
  • Host indoleamine 2,3-dioxygenase: Contribution to systemic acquired tumor tolerance, 2012
    Journal Article, Academic Journal
  • Modulation of tumor tolerance in primary central nervous system malignancies, 2012
    Journal Article, Academic Journal

Research Interests

I am a physician-scientist and pediatric oncologist, concentrating on developing multi-modal chemo-immunotherapy for children with brain cancer. In my molecular immunology Ph.D. training, I was part of the research team that first reported the groundbreaking discovery of the immune-suppressive potential of indoleamine 2,3-dioxygenase (IDO) in human cancer, and the team that developed indoximod, a small-molecule inhibitor of the IDO pathway used in this proposal. I am the co-founder and Co-Director of the Pediatric Immunotherapy Program at Augusta University, where I oversee clinical trial operations.